New Data Gives Adherium Fuel To Accelerate Digital Tech Adoption in Drug Sector

New Data Gives Adherium Fuel To Accelerate Digital Tech Adoption in Drug Sector

  • February 2018 •
  • 3 pages •
  • Report ID: 5391425 •
  • Format: PDF
Summary
With nearly 40 published peer-reviewed journal articles under its belt, Adherium is hoping that the latest clinical data which underlines the ability of the company’s Smartinhaler to improve outcomes for children with poorly controlled asthma should boost the pairing of digital technologies with drugs. Adherium Ltd.’s Smartinhaler electronic monitoring tool – which incorporates reminder alarms and feedback – used with asthma medication delivery in children with poorly controlled asthma not only helps reduce the frequency of exacerbations, but also improves medication adherence significantly.